Proprio welcomed esteemed spine and medical device leader Tommy Carls to their leadership team, formally transitioning Carls from his role as Clinical Advisor to Vice President of Product Management & Marketing. Prior to serving as an independent medical device consultant, Mr. Carls’ served as the Vice President of Research and Development at Medtronic Spine & Biologics for 16 years. His background also includes Vice President of Marketing for the Thoracolumbar Systems group at Medtronic, and Director of Marketing for the Image Guided Spinal Surgery group.
“Tommy is a globally recognized expert and industry trailblazer – we’re honored to have him transition into an in-house role as our VP of Product Management & Marketing,” noted Gabriel Jones, CEO and co-founder of Proprio. “His background in medical technology and knowledge of the spine industry will be essential to Proprio’s ongoing growth and success.”
“Proprio is creating the new way of seeing in spinal deformity procedures through the incorporation of immersive and intelligent technologies within the operating room,” Tommy Carls emphasized. “The application of these technologies can help level the playing field for all spine surgeons while benefiting patient care and subsequent outcomes. I look forward to being a part of this revolutionary team, and to continuing to help bring this vision to life.”
About Tommy Carls
Carls received his Bachelor of Science in mechanical engineering from Tulane University and his MBA from the University of Memphis. He most recently served as the Vice President of Research and Development at Medtronic Spine & Biologics where he was responsible for all engineering activities for the $2.8 Billion medical technology group. Carls was formerly an independent medical device consultant, and served on Proprio’s Clinical Advisory Board before joining Proprio full-time as their Vice President of Product Management & Marketing in January 2022. He holds more than 80 patents, has led global teams of more than 150 engineers, and is held in high regard by the top clinical and industry leaders in the global spine market.